Conference Reports for NATAP

Back

DDW 2009 May 30 - June 4, 2009 McCormick Place: Chicago, Illinois     Association between HBV Replication and Serum ALT Changes is not Dependent on HBV Genotype and Mutants - (06/08/09)   Regression of Fibrosis/Cirrhosis with Long-Term Entecavir Therapy in Chronic Hepatitis B (CHB) Patients with Baseline Bridging Fibrosis or Cirrhosis: Results from Studies ETV-022, -027 and -901 - (06/08/09)   Long-Term Histological Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs - (06/08/09)   Risk and Predictors of HCC in People Less than 40 years of Age: Update from the R.E.V.E.A.L.-HBV Study - (06/08/09)   Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment - (06/08/09)   Entecavir Maintains a High Genetic Barrier to HBV Resistance Through 6 Years in Naïve Patients - (06/08/09)